# reload+after+2024-01-21 09:43:51.173908
address1§4721 Emperor Boulevard
address2§Suite 100
city§Durham
state§NC
zip§27703
country§United States
phone§919 474 6700
website§https://www.bioventus.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for precise bone sculpting, removing tumors, and tissue debridement. The company's restorative therapies include a bone healing system; skin allografts; and products that are used to support healing of wounds, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
fullTimeEmployees§970
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Mark L. Singleton', 'age': 53, 'title': 'Senior VP & CFO', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 444118, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Anthony P. Bihl III', 'age': 67, 'title': 'CEO & Director', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 4090845, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mike  Crowe B.S., M.B.A.', 'title': 'Senior Vice President of Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Crawford', 'title': 'Vice President of Investor Relations & Treasurer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': "Mr. Anthony  D'Adamio", 'age': 62, 'title': 'Senior VP, General Counsel & Corporate Secretary', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 618292, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Katrina J. Church J.D.', 'age': 61, 'title': 'Chief Compliance Officer', 'yearBorn': 1962, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Helen  Leupold', 'title': 'Senior VP & Chief Human Resources Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Larry  Chen', 'title': 'Managing Director of China & Asia Pacific', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§6
compensationRisk§9
shareHolderRightsRisk§6
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.491
priceToSalesTrailing12Months§0.61869186
currency§USD
dateShortInterest§1702598400
forwardEps§0.33
exchange§NMS
quoteType§EQUITY
shortName§Bioventus Inc.
longName§Bioventus Inc.
firstTradeDateEpochUtc§1613053800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§aaf60255-09a2-3cde-9bb5-c2187b176100
gmtOffSetMilliseconds§-18000000
targetHighPrice§7.0
targetLowPrice§6.0
targetMeanPrice§6.5
targetMedianPrice§6.5
recommendationMean§2.7
recommendationKey§hold
numberOfAnalystOpinions§2
quickRatio§0.869
grossMargins§0.6287
ebitdaMargins§0.09546
trailingPegRatio§None
